Floating tablet preparation of yolk immunoglobulin IgY for preventing and treating human gastric diseases

A technology of egg yolk immunoglobulin and gastric floating tablets, which is applied in the field of biomedicine and can solve problems such as poor pertinence, inconvenient use, and poor therapeutic effect

Inactive Publication Date: 2012-03-14
曹吉祥 +1
View PDF3 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, this kind of anti-Hp-IgY is made into concentrated liquid or freeze-dried powder, but it is inconvenient to use, the pertinence is not strong, and the treatment e

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Floating tablet preparation of yolk immunoglobulin IgY for preventing and treating human gastric diseases

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0066] Each tablet of this anti-HP-IgY gastric floating tablet consists of the following components (by weight):

[0067] Anti-HP-IgY 20mg

[0068] Lactose (dried) 68mg

[0069] Mannitol 24mg

[0070] Sodium carboxymethylcellulose 105mg

[0071] Hydroxypropyl Methyl Cellulose 55mg

[0072] Polyvinylpyrrolidone 15mg

[0073] Methylcellulose (17~23cps) 75.6mg

[0074] Glyceryl monostearate 29.4mg

[0075] Talc powder 8mg

[0076] Magnesium Stearate 5mg

[0077] The preparation process of the anti-HP-IgY gastric floating tablet is as follows:

[0078] Measure and weigh each component according to the above ratio, grind the excipients: lactose, mannitol, polyvinylpyrrolidone, methylcellulose, glyceryl monostearate, and talc through an 80-mesh sieve, mix well, and dry at 45°C Dry; the main drug anti-HP-IgY is freeze-dried powder, and the main and auxiliary materials are mixed; add binders: sodium carboxymethyl cellulose, hydroxypropyl methyl cellulose, and make soft materi...

Embodiment 2

[0080] Each tablet of this anti-HP-IgY gastric floating tablet consists of the following components (by weight):

[0081] Anti-HP-IgY 30mg

[0082] Lactose (dried) 60mg

[0083] Mannitol 28mg

[0084] Sodium carboxymethylcellulose 125mg

[0085] Hydroxypropyl Methyl Cellulose 60mg

[0086] Polyvinylpyrrolidone 10mg

[0087] Methylcellulose (17~23cps) 65mg

[0088] Glyceryl monostearate 30mg

[0089] Talc powder 10mg

[0090] Magnesium Stearate 8mg

[0091] The preparation process of the anti-HP-IgY gastric floating tablet is as follows:

[0092] Measure and weigh each component according to the above ratio, grind the excipients: lactose, mannitol, polyvinylpyrrolidone, methylcellulose, glyceryl monostearate, and talc through an 80-mesh sieve, mix well, and dry at 50°C Dry; the main drug anti-HP-IgY is freeze-dried powder, and the main and auxiliary materials are mixed; add binders: sodium carboxymethyl cellulose, hydroxypropyl methyl cellulose, and make soft materials...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Hardnessaaaaaaaaaa
Hardnessaaaaaaaaaa
Login to view more

Abstract

The invention discloses a biological preparation capable of preventing and treating human gastric diseases, i.e., an anti-Helicobacter pylori specific yolk immunoglobulin (anti-HP-IgY) preparation, and especially to a novel dosage form thereof, i.e., a floating tablet in stomach, and the invention belongs to the technical field of biomedicines. The anti-HP-IgY gastric floating tablet uses yolk immunoglobulin specifically resisting Helicobacter pylori (i.e., anti-HP-IgY) as an active component and hydrophobic pharmaceutic adjuvants and hydrophilic pharmaceutic adjuvants as auxiliary components. The gastric floating tablet enables retention time of the active component (anti-HP-IgY) in stomach to be prolonged, which is very helpful for anti-HP-IgY in killing of Helicobacter pylori Hp intermittently floating upward from pylorus; the anti-HP-IgY gastric floating tablet has the advantages of strong specificity, no drug resistance, no toxic and side effects and good thermal stability, acid resistance and antiprotease performance. Raw materials for preparing the tablet are easily available, and a manufacturing method for the table is simple and is convenient for popularization and utilization.

Description

technical field [0001] The present invention relates to a kind of biological agent capable of preventing and treating human gastric diseases—specific egg yolk immunoglobulin (anti-HP-IgY) preparation against Helicobacter pylori, and especially relates to its new dosage form—gastric floating tablet, which belongs to biological field of medical technology. Background technique [0002] Stomach disease, or stomach disease, is actually a general term for many diseases. They have similar symptoms, such as epigastric discomfort, pain, fullness after meals, acid regurgitation, and even nausea and vomiting. Clinically common stomach diseases include acute gastritis, chronic gastritis, gastric ulcer, duodenal ulcer, gastroduodenal ulcer, and benign and malignant tumors of the stomach. [0003] In 1982, Australian scholars Barry Marshall and Robin Warren discovered Helicobacter pylori (Helicobacter pylori, hereinafter referred to as Hp), and proved that the bacteria infecting the st...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K9/22A61K39/395A61P1/00
Inventor 曹吉祥国为民
Owner 曹吉祥
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap